Latest NewsJun 18, 2025HiFiBiO Therapeutics to Present Preclinical Data of Three Leading I&I Programs at the 2025 Annual Meeting of the Federation of Clinical Immunology SocietiesAll Filter By: Year20252024202320222021202020192018201720162015Sep 17, 2020HiFiBiO Therapeutics Presents Novel Approach to Patient Stratification Demonstrating DIS® Single-Cell Platform at 2020 AACR Tumor Heterogeneity ConferenceSep 3, 2020KITE AND HIFIBIO THERAPEUTICS PARTNER TO DISCOVER NOVEL TARGETS AND ANTIBODIES AGAINST ACUTE MYELOID LEUKEMIAAug 26, 2020HiFiBiO Therapeutics Submits IND Application for Fully Human SARS-CoV-2 Neutralizing Antibody for the Treatment of COVID-19 PatientsAug 17, 2020HiFiBiO Therapeutics Collaborates with Coronavirus Immunotherapy Consortium in the Fight Against COVID-19Jul 3, 2020HFB9-2, a novel Galectin-9 neutralizing antibody to reverse immune suppression in the tumor microenvironment< 1 … 9 10 11 12 13 … 17 >
